+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ribavirin"

From
Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatitis Therapeutics Market Report 2025 - Product Thumbnail Image

Hepatitis Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Hepatitis Drugs Market Report 2025 - Product Thumbnail Image

Hepatitis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bird Flu Treatment - Global Strategic Business Report - Product Thumbnail Image

Bird Flu Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 285 Pages
  • Global
From
From
Hepatitis C Virus Infection- Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis C Virus Infection- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
West Nile - Pipeline Insight, 2025 - Product Thumbnail Image

West Nile - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lassa Fever - Pipeline Insight, 2025 - Product Thumbnail Image

Lassa Fever - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
Loading Indicator

Ribavirin is an antiviral drug used to treat a variety of infectious diseases, including hepatitis C, respiratory syncytial virus, and Lassa fever. It is a nucleoside analog, meaning it works by interfering with the replication of viral genetic material. Ribavirin is typically administered orally or intravenously, and is often used in combination with other antiviral drugs. Ribavirin is a widely used drug in the infectious diseases market, and is often prescribed in combination with other antiviral drugs. It is generally well-tolerated, but can cause side effects such as anemia, fatigue, and nausea. The market for ribavirin is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, and Cipla. Other companies such as Dr. Reddy's Laboratories, Sun Pharmaceuticals, and Lupin also offer ribavirin products. Show Less Read more